The Major Depressive Disorder market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
Major Depressive Disorder: An Overview
Major Depressive Disorder (MDD), also referred to as depression, is a serious medical illness that disrupts a person’s mood, behavior, and thought processes, apart from degrading physical health.
Major Depressive Disorder Market Key Facts
According to the Anxiety & Depression Association, the prevalence of major depressive episodes was higher among adult females (8.7%) compared to males (5.3%). The prevalence of adults with a major depressive episode was highest among individuals aged 18-25 (13.1%).
According to the Anxiety & Depression Association of America, In 2017, around 17.3 million aged 18 years or older in the U.S. had experienced at least one major depressive episode in the last year, which represented 6.7% of all American adults. While major depressive disorder can develop at any age, the median age at onset is 32.5 years old.
Among the European 5 countries, France had the highest prevalent population of Major Depressive Disorder (MDD), followed by Germany and Spain. On the other hand, the United Kingdom had the lowest prevalent population of Major Depressive Disorder (MDD).
The Major Depressive Disorder (MDD) Market Size is expected to increase during the study period owing to the rising prevalent population in the 7MM, along with the expected entry of premium price assets such as nociceptin receptor antagonist, Botox, selective orexin 2 receptor antagonist.
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Major Depressive Disorder market size by analyzing the impact of current and emerging therapies in the market. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies.
The report gives complete detail of the Major Depressive Disorder market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.
Major Depressive Disorder Epidemiology
The epidemiology section covers insights into the historical and current Major Depressive Disorder patient pool and forecasted trends for every seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool, future trends, and assumptions undertaken.
Major Depressive Disorder Epidemiology Segmentation –
Prevalent Cases of Major Depressive Disorder
Severity-specific Prevalent Pool of Major Depressive Disorder
Age-Specific Cases of Major Depressive Disorder
Gender-Specific Prevalent Pool of Major Depressive Disorder
Treatable Patient Pool of Major Depressive Disorder
Relapse/Refractory Patient Pool of Major Depressive Disorder
Major Depressive Disorder Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Major Depressive Disorder market or expected to get launched during the study period. The analysis covers Major Depressive Disorder market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Major Depressive Disorder Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Request for Sample PDF Report – https://www.delveinsight.com/sample-request/major-depressive-disorder-market
Major Depressive Disorder Therapeutics Analysis
The emerging treatment options in the Major Depressive Disorder (MDD) Landscape aim to improve the responses which are inadequate with respect to standard antidepressant therapies.
Some of the key companies in the Major Depressive Disorder Market include:
Johnson & Johnson
And many others.
Major Depressive Disorder Therapies covered in the report include:
And many more.
Get More Detailed Insights Into the Emerging Therapies & Key Companies – https://www.delveinsight.com/sample-request/major-depressive-disorder-market
Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Major Depressive Disorder Competitive Intelligence Analysis
4. Major Depressive Disorder Market Overview at a Glance
5. Major Depressive Disorder Disease Background and Overview
6. Major Depressive Disorder Patient Journey
7. Major Depressive Disorder Epidemiology and Patient Population
8. Major Depressive Disorder Treatment Algorithm, Current Treatment, and Medical Practices
9. Major Depressive Disorder Unmet Needs
10. Key Endpoints of Major Depressive Disorder Treatment
11. Major Depressive Disorder Marketed Products
12. Major Depressive Disorder Emerging Therapies
13. Major Depressive Disorder Seven Major Market Analysis
14. Attribute Analysis
15. Major Depressive Disorder Market Outlook (7 major markets)
16. Major Depressive Disorder Access and Reimbursement Overview
17. KOL Views on the Major Depressive Disorder Market.
18. Major Depressive Disorder Market Drivers
19. Major Depressive Disorder Market Barriers
21. DelveInsight Capabilities
*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.
Download Sample PDF Report – https://www.delveinsight.com/sample-request/major-depressive-disorder-market
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Other Latest Reports By DelveInsight
DelveInsight’s “Paraganglioma Market” report delivers an in-depth understanding of the historical and forecasted epidemiology, the Paraganglioma market size, shares, and trends analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan) as well as the emerging therapies and key companies in the therapeutic domain.
Company Name: DelveInsight Business Research
Contact Person: Shruti Thakur
Email: Send Email
Address:304 S. Jones Blvd #2432
City: Las Vegas
Country: United States